CAR T-cell (chimeric antigen receptor T-cell) therapy is a recent, exciting advancement as a form of immunotherapy, offering a new, […]Read More.
Researchers have revealed the important role of epigenetic regulation-mediated metabolic reprogramming in lung cancer’s capacity to resist molecular targeted therapy.Read More.
Researchers have shown the key role that a protein called Ran plays in the mobility of ovarian cancer cells. They demonstrated these cells cannot migrate from cancerous sites without the help of Ran.Read More.
A worldwide coalition of researchers and clinicians has agreed that light therapy is among the most effective interventions for the prevention of oral mucositis, painful ulcers in the mouth resulting from cancer therapy.Read More.
New research that uncovers the mechanism behind the newest generation of cancer drugs is opening the door for better targeted therapy.Read More.
A layer of cells that look like normal stomach lining on top of sites of stomach cancer can make it difficult to spot after removal of a Helicobacter pylori infection.Read More.
The biliary microbiome – the collection of bacteria present in the bile ducts – was altered in patients who received neoadjuvant therapy prior to undergoing surgery for pancreatic cancer.Read More.
A study led by researchers at RCSI’s Department of Chemistry has the potential to help surgeons more accurately remove tumours and detect cancer in lymph nodes during surgery.Read More.
Researchers have identified a new drug combination that is effective against metastatic uveal melanoma cells in preclinical studies.Read More.
Researchers have discovered a way to improve immune-based treatments, such as adoptive T-cell therapy (ACT) and haematopoietic stem cell transplantation (HSCT), by modulating T-cells with thioredoxin, a powerful, naturally occurring antioxidant molecule.Read More.